Detalhe da pesquisa
1.
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Gastric Cancer
; 27(3): 558-570, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308771
2.
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(4): 393-422, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015332
3.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
4.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 23(11): 1430-1440, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244398
5.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(2): 167-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130500
6.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
7.
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Invest New Drugs
; 38(5): 1533-1539, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898183
8.
Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric Cancer.
J Surg Res
; 255: 285-296, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574755
9.
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 420-435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718072
10.
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
Cancer
; 125(13): 2213-2221, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913304
11.
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(7): 855-883, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319389
12.
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(3): 370-398, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275037
13.
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
BMC Cancer
; 16: 468, 2016 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412386
14.
Rectal Cancer, Version 2.2015.
J Natl Compr Canc Netw
; 13(6): 719-28; quiz 728, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26085388
15.
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.
Oncologist
; 19(6): 637-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821822
16.
Colon cancer, version 3.2014.
J Natl Compr Canc Netw
; 12(7): 1028-59, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24994923
17.
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer.
Oncologist
; 18(4): 377-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580238
18.
Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.
Oncologist
; 18(3): 281-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23429739
19.
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw
; 11(5): 519-28, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23667203
20.
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw
; 11(2): 141-52; quiz 152, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23411381